ArticleInflammopharmacology2020

VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease.

Leo R Fitzpatrick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.